OMIC insider transaction filings
Singular Genomics Systems, Inc. — 15 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2025-02-27. Screen OMIC transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2025-02-27 | 4 | TANG KEVIN — 10% owner TANG CAPITAL MANAGEMENT LLC — 10% owner TANG CAPITAL PARTNERS LP — 10% owner | Disposition to issuer (D): 372,000 | EDGAR |
| 2025-02-25 | 4 | Spaventa Andrew — Chief Executive Officer, Director | Disposition to issuer (D): 325 · Disposition to issuer (D): 5,271 · Disposition to issuer (D): 137,629 · Disposition to issuer (D): 85 · Disposition to issuer (D): 42,881 (derivative) @ $1.10 · Disposition to issuer (D): 33,333 (derivative) @ $0 · +3 more | EDGAR |
| 2025-02-25 | 4 | Meeter Dalen — Chief Financial Officer | Disposition to issuer (D): 9,502 · Disposition to issuer (D): 833 (derivative) @ $0 · Disposition to issuer (D): 1,666 (derivative) @ $0 · Disposition to issuer (D): 6,249 (derivative) @ $0 · Disposition to issuer (D): 6,666 (derivative) @ $0 · Disposition to issuer (D): 6,000 (derivative) @ $20 · +1 more | EDGAR |
| 2025-02-25 | 4 | Glezer Eli N. — Chief Scientific Officer | Disposition to issuer (D): 155,583 · Disposition to issuer (D): 16,666 (derivative) @ $0 · Disposition to issuer (D): 7,999 (derivative) @ $0 · Disposition to issuer (D): 6,000 (derivative) @ $20 · Disposition to issuer (D): 2,250 (derivative) @ $20 | EDGAR |
| 2025-02-25 | 4 | Ghai Jyotsna — Chief Operating Officer | Disposition to issuer (D): 3,283 · Disposition to issuer (D): 13,333 (derivative) @ $9.20 · Disposition to issuer (D): 3,000 (derivative) @ $20 · Disposition to issuer (D): 4,583 (derivative) @ $20 | EDGAR |
| 2025-02-25 | 4 | Eisenberg Marcia — Director | Disposition to issuer (D): 4,933 (derivative) @ $0 · Disposition to issuer (D): 1,850 (derivative) @ $8.84 | EDGAR |
| 2025-02-25 | 4 | Ryan Jason — Director | Disposition to issuer (D): 1,333 (derivative) @ $0 · Disposition to issuer (D): 1,541 (derivative) @ $0 · Disposition to issuer (D): 2,466 (derivative) @ $0 · Disposition to issuer (D): 2,466 (derivative) @ $8.84 | EDGAR |
| 2025-02-25 | 4 | Kamdar Kim P. — Director | Disposition to issuer (D): 15,000 · Disposition to issuer (D): 3,763,985 · Disposition to issuer (D): 15,000 · Disposition to issuer (D): 666 (derivative) @ $0 · Disposition to issuer (D): 1,541 (derivative) @ $0 · Disposition to issuer (D): 2,466 (derivative) @ $0 · +1 more | EDGAR |
| 2025-02-25 | 4 | Mardis Elaine R — Director | Disposition to issuer (D): 1,333 (derivative) @ $0 · Disposition to issuer (D): 642 (derivative) @ $0 · Disposition to issuer (D): 2,466 (derivative) @ $0 · Disposition to issuer (D): 2,466 (derivative) @ $8.84 | EDGAR |
| 2025-02-25 | 4 | Pellini Michael J — Director | Disposition to issuer (D): 26,834 · Disposition to issuer (D): 324,388 · Disposition to issuer (D): 916 (derivative) @ $0 · Disposition to issuer (D): 2,083 (derivative) @ $0 · Disposition to issuer (D): 3,333 (derivative) @ $0 · Disposition to issuer (D): 3,333 (derivative) @ $8.84 | EDGAR |
| 2025-02-25 | 4 | BARKER DAVID L — Director | Disposition to issuer (D): 60,000 · Disposition to issuer (D): 1,000,000 · Disposition to issuer (D): 666 (derivative) @ $0 · Disposition to issuer (D): 1,541 (derivative) @ $0 · Disposition to issuer (D): 2,466 (derivative) @ $0 · Disposition to issuer (D): 2,466 (derivative) @ $8.84 | EDGAR |
| 2025-02-14 | 4 | Spaventa Andrew — Chief Executive Officer, Director | Option exercise (M): 1,907 · Sale (S): 800 @ $19.89 · Gift (G): 1,107 @ $0 · Gift (G): 1,107 @ $0 · Option exercise (M): 1,907 (derivative) @ $0 | EDGAR |
| 2025-02-11 | 4 | Meeter Dalen — Chief Financial Officer | Option exercise (M): 500 · Option exercise (M): 500 (derivative) | EDGAR |
| 2025-02-11 | 4 | Glezer Eli N. — Chief Scientific Officer | Option exercise (M): 500 · Option exercise (M): 500 (derivative) | EDGAR |
| 2025-02-11 | 4 | Ghai Jyotsna — Chief Operating Officer | Option exercise (M): 250 · Option exercise (M): 250 (derivative) | EDGAR |
Recent 8-K events — Singular Genomics Systems, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2025-02-27 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.01 — Completion of Acquisition or Disposition of Assets 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-02-19 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2025-02-13 | 8-K | 8.01 — Other Events | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=OMIC returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →